🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Isabelle R. Weir

Cancer Research And Biostatistics

ORCID: 0000-0002-5098-0671

MathematicsMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial”.

A 3-month clofazimine–rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00436-0

N/A

0.315DataRank · unranked

4 citations

Isabelle R. Weir, Kimberly K. Scarsi, Alberto Mendoza‐Ticona, Samuel Pierre, Luke Hall +30 more

An evaluation of confidence intervals for a cumulative proportion to enable decisions at interim reviews of single-arm trials

Contemporary Clinical Trials(2024)10.1016/j.cct.2024.107453

N/A

0.104DataRank · unranked

1 citations

Linda J. Harrison, Isabelle R. Weir

Treatment Effect Measures for Culture Conversion Endpoints in Phase IIb Tuberculosis Treatment Trials

Clinical Infectious Diseases(2021)10.1093/cid/ciab576

N/A

0DataRank · unranked

4 citations

Sean Wasserman, Isabelle R. Weir

Conjugated hyperbilirubinemia associated with accidental rifapentine overdose

The International Journal of Tuberculosis and Lung Disease(2024)10.5588/ijtld.23.0494

N/A

0DataRank · unranked

2 citations

Fahd Naufal, Alberto Mendoza‐Ticona, Elin M. Svensson, Isabelle R. Weir, Kimberly K. Scarsi +4 more

Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trial

AIDS(2025)10.1097/qad.0000000000004243

N/A

0DataRank · unranked

3 citations

Aya Awwad, Gerald S. Bloomfield, Isabelle R. Weir, Heather J. Ribaudo, Markella V. Zanni +18 more

“Six months is a lot of time to lie”: Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trial

Research Square(2025)10.21203/rs.3.rs-8277920/v1

N/A

0DataRank · unranked

0 citations

Cecilia Kanyama, Francis Makiya, John Metcalfe, Charity Potani, Kimberly K. Scarsi +3 more